Loading...
NPI 1053926642 · Metairie, LA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Atc Testing And Screening Services LLC is a clinical medical laboratory provider located in Metairie, Louisiana. This profile covers 1 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Atc Testing And Screening Services LLC |
| Address | 4532 W Napoleon Ave Ste 202 |
| City | Metairie |
| State | LA |
| ZIP | 70001 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | September 10, 2020 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $9.7M |
| Medicaid | $11.3K |
ATC TESTING AND SCREENING SERVICES LLC is classified under Clinical Medical Laboratory and its reported billing pattern is heavily focused on COVID-19 testing services. The Medicare dataset is entirely driven by K1034 (Provision of covid-19 test, nonprescription self-administered and self-collected use), and the Medicaid mix includes both immunoassay lab testing (87811) and the same K1034 code, indicating the operation combines large-scale distribution of self-administered test kits with some technical lab testing activity.
Medicare revenue is highly concentrated: the precomputed top-3 Medicare codes account for 100.0% of the provider’s Medicare revenue, and K1034 alone is reported as $9.9M revenue (100.0% of this provider's total Medicare revenue) from 822.1K claims at $12 avg paid/claim. This concentration implies the provider’s Medicare business is effectively mono-line and directly tied to reimbursement and demand for K1034.
On Medicaid the top-3 codes likewise account for 100.0% of Medicaid revenue, with 87811 generating $9.8K (87.2% of this provider's total Medicaid revenue) and K1034 contributing $1.4K (12.8% of this provider's total Medicaid revenue). Medicaid revenue is tiny in absolute terms compared with Medicare ($11.3K total Medicaid vs $9.7M total Medicare), so the provider is effectively Medicare-dominated in scale.
The provider’s competitive standing for K1034 on Medicare is exceptional: K1034 ranks #54 of 30143 providers nationally (100th percentile; extreme outlier), marking ATC TESTING AND SCREENING SERVICES LLC as a nationally high-volume supplier for that code. By contrast, for Medicaid the lab immunoassay code 87811 ranks #156 of 303 in-state (49th percentile; typical, unremarkable volume), indicating modest in-state lab testing participation.
There is an interesting divergence in state-level ranking versus dollar impact for K1034 on Medicaid: K1034 is ranked #2 of 102 providers in-state (99th percentile; notably above typical state volume) but represents only $1.4K (12.8% of Medicaid revenue) because the reported avg paid/claim for that code on Medicaid is $1. This signals high claim counts or distribution activity for K1034 in-state but very low unit reimbursement under Medicaid.
Tenure and timing align with pandemic-era activity: the NPI was enumerated on 2020-09-10 (~6 years ago), which corresponds to the period when COVID-19 testing services expanded rapidly. The combination of a Clinical Medical Laboratory taxonomy and a start date in 2020 supports the interpretation that the organization was established or repurposed to serve COVID testing demand.
Unit economics differ materially across payers and codes: Medicare K1034 shows $12 avg paid/claim leading to $9.9M revenue from 822.1K claims, while Medicaid payments are lower ($30 avg paid/claim for 87811 and $1 avg paid/claim for K1034). Analysts should note that revenue exposure depends on both high claim volumes and per-claim payment levels, with Medicare volume and payment producing nearly all reported revenue.
For payers and provider analysts monitoring market or contract risk, the business is vulnerable to changes in K1034 reimbursement or demand because Medicare revenue of $9.7M is essentially tied to that code (top-3 = 100.0%). Monitoring future utilization, coding policy changes for K1034, and any shifts in test distribution models will be important because a policy or demand shift could materially affect this provider’s reported revenues.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 822,060 | $10 | $9.9M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 1 | 410 | 250 | $10 | $57.8K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 330 | $30 | $9.8K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1,440 | $1 | $1.4K |
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 156 | 300 | 360 | $20 | $57.3K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 2 | 100 | 40 | $1 | $150 |
Other providers in the same ZIP code as Atc Testing And Screening Services LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.